Adrenalectomy for incidental and symptomatic phaeochromocytoma : retrospective multicentre study based on the Eurocrine® database
(2021) In The British journal of surgery 108(10). p.1199-1206- Abstract
BACKGROUND: Phaeochromocytoma is sometimes not diagnosed before surgery and may present as an adrenal incidentaloma. The aim of this study was to investigate differences in clinical presentation and perioperative outcome in patients with subclinical and symptomatic phaeochromocytoma, and in patients operated with and without preoperative α-blockade. METHODS: This was a retrospective observational study of patients with a histopathological diagnosis of phaeochromocytoma registered in Eurocrine®, the European registry for endocrine tumours, between 1 January 2015 and 31 March 2020. Patient characteristics, clinical presentation, tumour detection, and perioperative variables were analysed. RESULTS: Some 551 patients were included. Of... (More)
BACKGROUND: Phaeochromocytoma is sometimes not diagnosed before surgery and may present as an adrenal incidentaloma. The aim of this study was to investigate differences in clinical presentation and perioperative outcome in patients with subclinical and symptomatic phaeochromocytoma, and in patients operated with and without preoperative α-blockade. METHODS: This was a retrospective observational study of patients with a histopathological diagnosis of phaeochromocytoma registered in Eurocrine®, the European registry for endocrine tumours, between 1 January 2015 and 31 March 2020. Patient characteristics, clinical presentation, tumour detection, and perioperative variables were analysed. RESULTS: Some 551 patients were included. Of these, 486 patients (88.2 per cent) had a preoperative diagnosis of phaeochromocytoma. Tumours were detected as incidentalomas in 239 patients (43.4 per cent) and 265 (48.1 per cent) had a preoperative diagnosis of hypertension. Preoperative α-blockade was more frequently used in patients with a known phaeochromocytoma (350, 90.9 per cent) than in patients with other indications for adrenalectomy (16, 31 per cent). Complications did not differ between patients who had surgery because of catecholamine excess compared with those who had other indications for surgery (19 (3.9 per cent) versus 2 (3 per cent); P = 0.785), nor did the conversion rate from minimally invasive to open surgery differ between the groups. There were no obvious differences in complications, according to the Clavien-Dindo classification, based on preoperative α-blockade or not. CONCLUSION: Subclinical phaeochromocytoma detected incidentally is common. A significant proportion of patients with phaeochromocytoma did not have α-blockade before surgery, without an apparent effect on complications.
(Less)
- author
- Hallin Thompson, L. LU ; Makay, Ö ; Brunaud, L. ; Raffaelli, M. and Bergenfelz, A. LU
- author collaboration
- organization
- publishing date
- 2021-10-23
- type
- Contribution to journal
- publication status
- published
- subject
- in
- The British journal of surgery
- volume
- 108
- issue
- 10
- pages
- 8 pages
- publisher
- Oxford University Press
- external identifiers
-
- scopus:85120834431
- pmid:34270711
- ISSN
- 1365-2168
- DOI
- 10.1093/bjs/znab199
- language
- English
- LU publication?
- yes
- id
- 78d53ef7-38ba-4a29-921b-93f790675209
- date added to LUP
- 2022-02-03 11:24:11
- date last changed
- 2024-06-18 06:09:08
@article{78d53ef7-38ba-4a29-921b-93f790675209,
abstract = {{<p>BACKGROUND: Phaeochromocytoma is sometimes not diagnosed before surgery and may present as an adrenal incidentaloma. The aim of this study was to investigate differences in clinical presentation and perioperative outcome in patients with subclinical and symptomatic phaeochromocytoma, and in patients operated with and without preoperative α-blockade. METHODS: This was a retrospective observational study of patients with a histopathological diagnosis of phaeochromocytoma registered in Eurocrine®, the European registry for endocrine tumours, between 1 January 2015 and 31 March 2020. Patient characteristics, clinical presentation, tumour detection, and perioperative variables were analysed. RESULTS: Some 551 patients were included. Of these, 486 patients (88.2 per cent) had a preoperative diagnosis of phaeochromocytoma. Tumours were detected as incidentalomas in 239 patients (43.4 per cent) and 265 (48.1 per cent) had a preoperative diagnosis of hypertension. Preoperative α-blockade was more frequently used in patients with a known phaeochromocytoma (350, 90.9 per cent) than in patients with other indications for adrenalectomy (16, 31 per cent). Complications did not differ between patients who had surgery because of catecholamine excess compared with those who had other indications for surgery (19 (3.9 per cent) versus 2 (3 per cent); P = 0.785), nor did the conversion rate from minimally invasive to open surgery differ between the groups. There were no obvious differences in complications, according to the Clavien-Dindo classification, based on preoperative α-blockade or not. CONCLUSION: Subclinical phaeochromocytoma detected incidentally is common. A significant proportion of patients with phaeochromocytoma did not have α-blockade before surgery, without an apparent effect on complications.</p>}},
author = {{Hallin Thompson, L. and Makay, Ö and Brunaud, L. and Raffaelli, M. and Bergenfelz, A.}},
issn = {{1365-2168}},
language = {{eng}},
month = {{10}},
number = {{10}},
pages = {{1199--1206}},
publisher = {{Oxford University Press}},
series = {{The British journal of surgery}},
title = {{Adrenalectomy for incidental and symptomatic phaeochromocytoma : retrospective multicentre study based on the Eurocrine® database}},
url = {{http://dx.doi.org/10.1093/bjs/znab199}},
doi = {{10.1093/bjs/znab199}},
volume = {{108}},
year = {{2021}},
}